← FDA Drug Approvals (Drugs@FDA)

BLUDIGO

NDA · New Drug Application · Sponsor: PROVEPHARM SAS · Approved 2022-07-08

Drug application

FDA Application #

NDA216264

Application type

New Drug Application

Brand name

BLUDIGO

Generic name

INDIGOTINDISULFONATE SODIUM

Active ingredients

INDIGOTINDISULFONATE SODIUM

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

PROVEPHARM SAS

Manufacturer

Sagent Pharmaceuticals

First approval

2022-07-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown